Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
FCPA
Zimmer Biomet Pays $30 Million to Resolve New FCPA Charges
Medical device maker Zimmer Biomet Holdings, Inc., agreed to pay $30.5 million to resolve Department of Justice (DOJ) and…
The Trump Administration: One Predictive Perspective
We recently had the pleasure of speaking with Michaeline Daboul, President and CEO of MediSpend, about the upcoming administration…
Teva Pharmaceutical to Pay $519 Million to Settle FCPA Charges
Right before the holiday weekend, news broke that Teva Pharmaceutical Industries had come to an agreement to pay $519 million in a…
AstraZeneca Pays $5.5 Million to Resolve FCPA Offenses
The United States Securities and Exchange Commission (SEC) has charged AstraZeneca PLC with violating the books and records and…
Is the Carrot Bigger Than the Stick? – The DOJ’s FCPA “Pilot…
Kurt Stitcher, Senior Compliance Consultant
The U.S. Department of Justice's FCPA Pilot Program is nominally designed to…
Aegerion Pharmaceuticals Reaches Settlement Agreements in Principle with…
Aegerion Pharmaceuticals has reached agreements in principle with the Department of Justice ("DOJ") and the Securities and…
Peeling Back the Olympus Onion – The Importance of Culture
This article examines an apparent breakdown in corporate culture that goes beyond the subsidiaries to the parent…
Novartis Korea in Kickback Investigation – Medical Journal Rebates
In a recent securities filing, Novartis alluded to future issues for the Swiss company. In their Interim Financial…
Novartis Settles China Foreign Corrupt Practices Complaint
Novartis AG has settled civil charges against the company, for $25 million to the United States Securities and Exchange…
Olympus Settlement and Corporate Integrity Agreement – FCPA and Anti…
The United States Department of Justice has announced a settlement with medical device maker Olympus, to the tune of…